Please find enclosed the newspaper advertisement for the Audited Standalone and Consolidated Financial Results for the half year and financial year ended 31st March 2025 published in Mumbai ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries Limited has submitted copies of a newspaper advertisement carrying its audited standalone and consolidated financial results for the half year and financial year ended 31 March 2025. The advertisement was published in two newspapers: Mumbai Lakshdeep and Financial Express, as required under SEBI listing rules. The results cover both standalone and consolidated performance for H2 FY25 and the full FY25. The signed copy was issued by Hasmukh Mehta, Chairman & Managing Director, and Hemal Mehta, Company Secretary, with the filing dated 21 April 2025. The published financial table was largely illegible in the OCR-scanned document, so specific revenue and profit figures could not be reliably extracted.
This is a routine regulatory compliance filing — the company is simply fulfilling the SEBI requirement to publish its audited FY25 results in newspapers. No new business information is being disclosed beyond what was already filed with the exchanges, so it should have little to no direct impact on the stock price. Investors should refer to the earlier detailed results filing for actual financial performance numbers.